Application no. and date | 08004265.8 (espacenet) (Federated) (European Patent Register), 20000825 | Patent/reg. no. and date | DK/EP 1925303, 20140924 | Publication date | 20080528 | Priority no. and date | SE 9903028, 19990827 | EP pub. no. and date |
EP 1925303 20080528 | Effective date | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50 65929 Frankfurt am Main, DE | Applicant ref. no. | Sanofi DE2000/A038EP-EPT2 | Inventor | Ljunggren, Anders, Ringspinnaregatan 5
43163 Mölndal, SE, Bender, Norbert, Wasserhohl 9
67098 Bad Dürckheim, DE, Schoelkens, Bernward, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, Rangoonwala, Badrudin, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, Gerstein, Hetzel, 5 Dromore Crescent
Hamilton Ontario L8S 4A8, CA, Dagenais, Gilles, 670 Chemin des Oies
St.-Nicholas Quebec J7A 3P8, CA, Yusuf, Salim, 48 Woodend Drive
Carlisle Ontario L0R 1H2, CA | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/41 (2006.01) , A61K 31/4178 (2006.01) , A61K 31/4184 (2006.01) , A61K 31/519 (2006.01) , A61P 3/10 (2006.01) , A61P 9/04 (2006.01) , A61P 9/10 (2006.01) | Title | Anvendelse af angiotensin II-type 1-receptorantagonister til forebyggelse af diabetes | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|